None

DUBLIN, Ireland and TREVOSE, Pa., Sept. 23, 2021 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc (NASDAQ: SBBP) (the “Company” or “Strongbridge”) today announced that the High Court of Ireland (the “Court”) has set the date of the final court hearing to sanction the proposed acquisition of Strongbridge by Xeris Pharmaceuticals, Inc. (“Xeris”) by means of scheme of arrangement (the “Scheme”) under Chapter 1 of Part 9 of the Irish Companies Act 2014 (the “Act”).

Related tickers: SBBP.

Prem Watsa’s 13F portfolio value increased from $2.87B to $3.11B this quarter. Fairfax Financials’ largest three stakes are Atlas Corp, BlackBerry, and Resolute Forest Products.

Related tickers: AGX, ATCO, ATCOL, BAM, BB, BEN, BKNG, BNS, BRK.A, BRK.B, CCAP, CHNG, CIGI, CVS, CVX, DAR, DENN, DIN, DK, FNF, GE, GM, GOOG, GOOGL, GRP.U, GTX, HP, HRB, IMAX, IRBT, J, KKR, KLIC, KSU, KW, LBRDA, LBRDK, LBRDP, LORL, LTRPA, LTRPB, LUMN, MCFT, MIDD, MRK, MU, MX, NUAN, NWPX, OGN, OR, PFE, QSR, RFP, SBBP, SLCA, TSM, UA, UAA, VMD, VOO, WW.